News & Updates
Filter by Specialty:
Continuing enzalutamide after progression improves PFS in mCRPC
In patients with metastatic castration-resistant prostate cancer (mCRPC) who experience disease progression while on enzalutamide treatment, continuing enzalutamide appears to improve progression-free survival (PFS), according to results of the phase IIIb PRESIDE trial.
Continuing enzalutamide after progression improves PFS in mCRPC
09 Mar 2022
New NSAID patch matches diclofenac gel for pain management in knee osteoarthritis
The novel topical nonsteroidal anti-inflammatory drug (NSAID) S-flurbiprofen plaster provides relief from pain that appears similar to that achieved with diclofenac gel in patients with knee osteoarthritis, in addition to being well tolerated, according to data from an open-label, noninferiority phase III study.
New NSAID patch matches diclofenac gel for pain management in knee osteoarthritis
09 Mar 2022
Use of alternative medicine not uncommon in melanoma patients
About one in four cutaneous melanoma patients use at least one type of complementary and alternative medicine (CAM), of which herbs and turmeric are the most popular, reveals a prospective study from a tertiary cancer centre in Turkey.
Use of alternative medicine not uncommon in melanoma patients
09 Mar 2022
Point-of-care diagnostics feasible for COVID-19 border testing
Point-of-care (POC) diagnostic methods, such as serology or nucleic acid amplification (NAAT) tests, have high specificity and sensitivity for the coronavirus disease 2019 (COVID-19) and can be effectively deployed as border control mechanisms, according to a recent Singapore study.
Point-of-care diagnostics feasible for COVID-19 border testing
09 Mar 2022
Female sex, hypertension, number of initial symptoms tied to long COVID risk
The risk of developing long COVID is high among women, hypertensives, and those with a higher number of initial symptoms, and these associations are independent of disease severity and clinical course, a study has found.